|
Compact Navigation System for CT-guided Needle Interventions
|
1UT1CA224886-01A1
|
$149,927
|
$149,927
|
TSE, TSZ HO
|
3T TECHNOLOGIES, LLC
|
|
Personalized precision dosing of biologic therapies in oncology
|
5R44CA217336-02
|
$720,363
|
$720,363
|
MESSMER, BRADLEY
|
ABREOS BIOSCIENCES, INC.
|
|
Feasibility of predicting AML response to induction chemotherapy
|
1R43CA221473-01
|
$299,999
|
|
HENDERSON, PAUL
|
ACCELERATED MEDICAL DIAGNOSTICS, LLC
|
|
Novel Glyco-tests to Predict Chemoresistance
|
1R43CA213766-01A1
|
$297,480
|
$297,480
|
RAZI, NAHID
|
ACCUDAVA, INC.
|
|
Novel Glyco-tests to Predict Chemoresistance
|
3R43CA213766-01A1S1
|
$50,000
|
$50,000
|
RAZI, NAHID
|
ACCUDAVA, INC.
|
|
Novel Glyco-tests to Predict Chemoresistance
|
3R43CA213766-01A1S2
|
$149,785
|
$149,785
|
RAZI, NAHID
|
ACCUDAVA, INC.
|
|
Magneto-electronic Sensing of Cancer in Urine
|
1R43CA221535-01
|
$220,000
|
$220,000
|
SANG, LIYUN
|
ACCURE HEALTH, INC.
|
|
Image-guided ultrasound ablation for precision targeting of prostate cancer
|
1R01CA230323-01
|
$580,217
|
$580,217
|
BURDETTE, EVERETTE
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
Innovation Corp Program and Commercialization Planning for Endoscopic Flexible Pancreatic Tumor Ablation System with Reduced Force Effector and Specialized Ablation Zone
|
3R43CA225169-01S1
|
$49,999
|
$49,999
|
SNOOK, KEVIN
|
ACTUATED MEDICAL, INC.
|
|
Fluorescent Nanodiamonds for Multiplexed Imaging and Diagnostics
|
1R43CA232901-01
|
$291,083
|
$291,083
|
SHENDEROVA, OLGA
|
ADAMAS NANOTECHNOLOGIES, INC.
|
|
Oral formulation for novel inhibitor of Ras driven cancers
|
1R43CA217502-01A1
|
$300,000
|
|
CANZONERI, JOSHUA
|
ADT PHARMACEUTICALS, LLC
|
|
Implantable iontophoresis chemotherapy delivery device for direct infusion of gemcitabine into pancreatic adenocarcinoma: Device development and First-in-Human clinical trial
|
4R44CA224460-02
|
$1,111,364
|
$1,111,364
|
DAUNCH, WILLIAM
|
ADVANCED CHEMOTHERAPY TECHNOLOGIES, INC.
|
|
The Hemopurifier Device for Targeted Removal of Breast Cancer Exosomes from the Blood Circulation
|
1R43CA232977-01
|
$298,444
|
$298,444
|
MARLEAU, ANNETTE
|
AETHLON MEDICAL, INC.
|
|
Novel Strategies for Precision T-cell Therapies
|
3R01CA198095-03S1
|
$107,431
|
$107,431
|
ALMO, STEVEN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Novel Strategies for Precision T-cell Therapies
|
5R01CA198095-03
|
$520,564
|
$520,564
|
ALMO, STEVEN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
3P30CA013330-45S1
|
$3,646,138
|
$145,846
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The role of tunneling nanotubes as a novel mode of tumor cell-macrophage communication
|
5F99CA212451-02
|
$44,044
|
|
HANNA, SAMER
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Tumor expressed B7x accelerates disease and is a novel target for immunotherapy
|
5F31CA183493-04
|
$49,044
|
|
OHAEGBULAM, KIM
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Molecular markers of risk of subsequent invasive breast cancer in women wth ductal carcinoma in situ
|
1R01CA218429-01
|
$1,513,571
|
|
ROHAN, THOMAS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Colon cancer risk-stratification via optical analysis of rectal ultrastructure
|
3R44CA199667-02S1
|
$2,000
|
$2,000
|
WALI, RAMESH
|
AMERICAN BIOOPTICS, LLC
|
|
Colon cancer risk-stratification via optical analysis of rectal ultrastructure
|
3R44CA199667-02S2
|
$126,060
|
$126,060
|
WALI, RAMESH
|
AMERICAN BIOOPTICS, LLC
|
|
Molecular, cancer-specific, intraoperative imaging of breast surgical margin assessment
|
1R41CA221595-01A1
|
$300,000
|
$300,000
|
SHIH, WEI-HENG
|
AQD LIFE SCIENCES, LLC
|
|
Charge sensitive optical detection for high-throughput study of small molecules
|
5R33CA202834-03
|
$378,392
|
$378,392
|
TAO, NONGJIAN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Create three-member project team to refine commercialization plans for AML-Mutation Counter, a tool to detect residual and recurrent leukemia.
|
3R41CA213690-01S1
|
|
$0
|
KAUFMANN, WILLIAM
|
ASYSTBIO LABORATORIES, LLC
|
|
Genetic Analysis of Myeloproliferative Disease
|
3R01CA076167-14S1
|
$24,361
|
|
COWELL, JOHN
|
AUGUSTA UNIVERSITY
|
|
DACH1/Eya Cell fate determination factor and mammary tumorigenesis
|
7R01CA132115-08
|
$428,056
|
|
PESTELL, RICHARD
|
BARUCH S. BLUMBERG INSTITUTE
|
|
Area A: In-Depth Proteome Mapping of the Tumor Microenvironment with Single-Cell Resolution
|
1R33CA225248-01
|
$1,744,991
|
|
KELLY, RYAN
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
PNNL Proteome Characterization Center
|
5U24CA210955-02
|
$1,091,415
|
|
LIU, TAO
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
SPORE in Lymphoma
|
5P50CA126752-12
|
$2,297,796
|
$275,736
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Racial Disparity in Bladder Cancer and Identification of Altered Metabolism in African American Compare to European Bladder Cancer
|
1R01CA220297-01
|
$370,749
|
|
PUTLURI, NAGIREDDY
|
BAYLOR COLLEGE OF MEDICINE
|
|
iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC
|
5U24CA210954-02
|
$973,045
|
|
ZHANG, BING
|
BAYLOR COLLEGE OF MEDICINE
|
|
MACROPHAGE-MEDIATED IMMUNOSURVEILLANCE IN CANCER
|
4R00CA201075-03
|
$249,000
|
|
FENG, MINGYE
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
City of Hope Lymphoma SPORE
|
2P50CA107399-11A1
|
$2,500,000
|
$625,000
|
FORMAN, STEPHEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Diversity Supplement to Combined Breast MRI/Biomarker Strategies to Identify Aggressive Biology
|
3U01CA189283-03S1
|
$190,203
|
|
JONES, VERONICA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Targeting microRNAs to eradicate leukemia stem cells
|
1R01CA205247-01A1
|
$434,503
|
|
KUO, YA-HUEI
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Metabolic basis of B cell lineage leukemia relapse
|
7R35CA197628-02
|
$1,036,898
|
|
M?SCHEN, MARKUS
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
2P30CA033572-35
|
$2,543,187
|
$25,432
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S3
|
$865,000
|
$8,650
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-35S1
|
$43,750
|
$438
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Epigenetic damage in women living in LA food-desert zip codes
|
1R01CA220693-01
|
$719,296
|
|
SEEWALDT, VICTORIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Multifunctional immunoPET tracers for pancreatic and prostate cancer
|
7R01CA174294-06
|
$377,890
|
$377,890
|
WU, ANNA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Omega-3 fatty acids and ERPR(-) and HER-2/neu(+) breast cancer prevention
|
7R01CA164019-05
|
$92,521
|
|
YEE, LISA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Control of tumor growth and metastasis by the cytokine TSLP
|
3R01CA182783-04S1
|
$119,849
|
|
ZIEGLER, STEVEN
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Investigation and functional characterization of new drivers of mesenchymal tumorigenesis.
|
5K99CA212200-02
|
$102,130
|
|
GUARNERIO, JLENIA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A National Curriculum in Cancer Genomics for Residents and Medical Students
|
2R25CA168544-06
|
$255,425
|
|
HASPEL, RICHARD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Isolation and Assessment of Blood-Circulating Cancer Exosomes with LSS and SERS Lab on a Chip Optical Spectroscopic Instrument
|
1R01CA218382-01A1
|
$668,549
|
$668,549
|
PERELMAN, LEV
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Spectro-Holographic Instrument for Dynamic Sensing of Cancer Progression
|
1R01CA228029-01A1
|
$688,217
|
$688,217
|
PERELMAN, LEV
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
(PQ7) In Vivo Cellular Optical Imaging of Esophageal Tumors and Microenvironment
|
5R01CA205431-03
|
$522,325
|
$522,325
|
PERELMAN, LEV
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Discussions of Prognosis and Stopping Cancer Screening in Older Adults
|
1R21CA212386-01A1
|
$235,787
|
|
SCHONBERG, MARA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Parallel and high throughput isolation of cfDNA to target detection of rare, highly conserved nucleotide polymorphisms
|
1R43CA228923-01A1
|
$286,548
|
$286,548
|
MULLER, ROLF
|
BIOFLUIDICA, INC
|
Total relevant funding to Bioengineering for this search: $210,960,629
|